About Transcription factor Dp-2
Transcription factor Dp-2 (TFDP2) is a protein
from Homo sapiens identified by UniProt accession
Q14188, 446 residues long.
MolForge cross-references it against 0 known binders and
57 disease associations.
Target properties
| Protein name | Transcription factor Dp-2 |
| UniProt accession | Q14188 |
| Gene | TFDP2 |
| Organism | Homo sapiens |
| Length | 446 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (57)
Diseases linked to this target (Open Targets).
- mean corpuscular volume · score 0.48
- mean corpuscular hemoglobin · score 0.39
- creatinine measurement · score 0.35
- urate measurement · score 0.34
- glomerular filtration rate · score 0.33
- endometrial cancer · score 0.29
- head and neck squamous cell carcinoma · score 0.29
- breast adenocarcinoma · score 0.29
- lung adenocarcinoma · score 0.29
- squamous cell lung carcinoma · score 0.28
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q14188-F1 | alphafold | PREDICTED | 65.18 | — |
Amino-acid sequence (446 residues)
MTAKNVGLTS TNAEVRGFID QNLSPTKGNI SFVAFPVSNT NSPTKILPKT LGPINVNVGP QMIISTPQRL TSSGSVLIGS PYTPAPAMVT QTHIAEATGW VPGDRKRARK FIDSDFSESK RSKKGDKNGK GLRHFSMKVC EKVQRKGTTS YNEVADELVS EFTNSNNHLA ADSAYDQKNI RRRVYDALNV LMAMNIISKE KKEIKWIGLP TNSAQECQNL EIEKQRRIER IKQKRAQLQE LLLQQIAFKN LVQRNRQNEQ QNQGPPALNS TIQLPFIIIN TSRKTVIDCS ISSDKFEYLF NFDNTFEIHD DIEVLKRMGM SFGLESGKCS LEDLKLAKSL VPKALEGYIT DISTGPSWLN QGLLLNSTQS VSNLDLTTGA TLPQSSVNQG LCLDAEVALA TGQFLAPNSH QSSSAASHCS ESRGETPCSF NDEDEEDDEE DSSSPE
Explore Transcription factor Dp-2 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets